2024 annual financial data
Sunshine Biopharma 2024 Operating margin
Sunshine Biopharma 2024 operating margin with verified reported values.
Direct answer
Operating margin was -16.67%.
Operating income was -5,812,121 USD and net income was -5,134,116 USD.
Operating cash flow was -12,531,180 USD.
Get free Sunshine Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 34,874,283 USD
- Operating income
- -5,812,121 USD
- Net income
- -5,134,116 USD
- Operating cash flow
- -12,531,180 USD